Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma.
Gasparetto C, Lentzsch S, Schiller G, Callander N, Tuchman S, Chen C, White D, Kotb R, Sutherland H, Sebag M, Baljevic M, Bensinger W, LeBlanc R, Venner C, Bahlis N, Rossi A, Biran N, Sheehan H, Saint-Martin JR, Van Domelen D, Kai K, Shah J, Shacham S, Kauffman M, Lipe B.
Gasparetto C, et al. Among authors: kai k.
EJHaem. 2020 Nov 8;2(1):56-65. doi: 10.1002/jha2.122. eCollection 2021 Feb.
EJHaem. 2020.
PMID: 35846104
Free PMC article.